Serum beta 2 microglobulin levels in patients with renal cell carcinoma

C. Selli, F. Cozzolino, M. Carini, R. Lenzi, D. Vercelli

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Serum B2m concentrations were evaluated preoperatively in 40 patients with renal cell carcinoma and normal renal function, as assessed by serum creatinine <1.4 mg/dl, and compared with those of 23 age-matched controls. Mean value ± SD was 3,088±966 ng/ml for renal cancer patients, while controls had a value of 1,800±240 ng/ml. Statistical analysis, performed by Student t test, revealed a very high degree of significance (p<0.0005). No statistically significant differences were found between groups of patients classified according to tumor stage and cell type. Seventy percent of renal cell carcinoma cases had preoperatively elevated serum levels of B2m.

Original languageEnglish (US)
Pages (from-to)261-263
Number of pages3
JournalUrological Research
Issue number5
StatePublished - Oct 1984


  • Beta 2 microglobulin
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Serum beta 2 microglobulin levels in patients with renal cell carcinoma'. Together they form a unique fingerprint.

Cite this